Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Jul 31, 2025, 1:07 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY TTMFY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Royalty/Licensing, Net
126.52K
Log In
Log In
Log In
Log In
Upgrade
Royalty/Licensing, Net Growth
11.35%
Log In
Log In
Log In
Log In
Upgrade
Direct Sales - Plastic Surgeons, Gross
13.72K
Log In
Log In
Log In
Log In
Upgrade
Direct Sales - Plastic Surgeons, Gross Growth
-36.86%
Log In
Log In
Log In
Log In
Upgrade
Evolutionary Medical Devices
-
Log In
Log In
Log In
Log In
Upgrade
Evolutionary Medical Devices Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY TTMFY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
140.24K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.61%
Log In
Log In
Log In
Log In
Upgrade